Literature DB >> 18082750

Treatment with dehydroepiandrosterone in vivo and in vitro inhibits reproduction, growth and viability of Taenia crassiceps metacestodes.

José Antonio Vargas-Villavicencio1, Carlos Larralde, Jorge Morales-Montor.   

Abstract

The aim of this work was to explore the effect of dehydroepiandrosterone (DHEA) on the establishment, growth and reproduction of the metacestode stage of the tapeworm Taenia crassiceps, both in vivo and in vitro. Administration of DHEA prior to infection in mice of both sexes reduced the parasite load by 50% compared with untreated mice. This protective effect was not associated with the immune response, since there was no effect of DHEA treatment on mRNA levels of IL-2, IFN-gamma, IL-4 or IL-10. DHEA treatment of infected mice increased androgen receptor expression in splenocytes of both sexes. Moreover, in vitro treatment of T. crassiceps with DHEA reduced reproduction, motility and viability in a dose- and time-dependent fashion. Results indicate that DHEA has strong negative direct modulatory effects on murine cysticercosis. We suggest the use of hormonal-analogues for protective purposes as a therapeutic approach to prevent murine cysticercosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18082750     DOI: 10.1016/j.ijpara.2007.10.011

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  7 in total

1.  Dehydroepiandrosterone sulfate directly activates protein kinase C-beta to increase human neutrophil superoxide generation.

Authors:  David J Radford; Keqing Wang; Joanne C McNelis; Angela E Taylor; Georg Hechenberger; Johann Hofmann; Hema Chahal; Wiebke Arlt; Janet M Lord
Journal:  Mol Endocrinol       Date:  2010-02-19

Review 2.  Neurocysticercosis: a review on status in India, management, and current therapeutic interventions.

Authors:  Rumana Ahmad; Tahmeena Khan; Bilal Ahmad; Aparna Misra; Anil K Balapure
Journal:  Parasitol Res       Date:  2016-10-24       Impact factor: 2.289

Review 3.  Boosting the Discovery of Small Molecule Inhibitors of Glucose-6-Phosphate Dehydrogenase for the Treatment of Cancer, Infectious Diseases, and Inflammation.

Authors:  Ana Koperniku; Adriana A Garcia; Daria Mochly-Rosen
Journal:  J Med Chem       Date:  2022-03-03       Impact factor: 8.039

4.  Glucose-6-phosphate dehydrogenase of trypanosomatids: characterization, target validation, and drug discovery.

Authors:  Shreedhara Gupta; Mariana Igoillo-Esteve; Paul A M Michels; Artur T Cordeiro
Journal:  Mol Biol Int       Date:  2011-04-04

5.  A new parasiticidal compound in T. solium cysticercosis.

Authors:  Romel Hernández-Bello; Galileo Escobedo; Julio Cesar Carrero; Claudia Cervantes-Rebolledo; Charles Dowding; James Frincke; Chris Reading; Jorge Morales-Montor
Journal:  Biomed Res Int       Date:  2012-12-20       Impact factor: 3.411

6.  A Nature-Inspired Design Yields a New Class of Steroids Against Trypanosomatids.

Authors:  Elena Aguilera; Cintya Perdomo; Alejandra Espindola; Ileana Corvo; Paula Faral-Tello; Carlos Robello; Elva Serna; Fátima Benítez; Rocío Riveros; Susana Torres; Ninfa I Vera de Bilbao; Gloria Yaluff; Guzmán Alvarez
Journal:  Molecules       Date:  2019-10-22       Impact factor: 4.411

7.  Dehydroepiandrosterone Effect on Toxoplasma gondii: Molecular Mechanisms Associated to Parasite Death.

Authors:  Saé Muñiz-Hernández; Angélica Luna-Nophal; Carmen T Gómez-De León; Lenin Domínguez-Ramírez; Olga A Patrón-Soberano; Karen E Nava-Castro; Pedro Ostoa-Saloma; Jorge Morales-Montor
Journal:  Microorganisms       Date:  2021-03-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.